The distal fallopian tube: A new model for pelvic serous carcinogenesis

Christopher P. Crum, Ronny Drapkin, Alexander Miron, Tan Ince, Michael Muto, David W. Kindelberger, Yonghee Lee

Research output: Contribution to journalArticle

326 Citations (Scopus)

Abstract

PURPOSE OF REVIEW: Research over the past 50 years has yielded little concrete information on the source of pelvic serous cancer in women, creating a knowledge gap that has adversely influenced our ability to identify, remove or prevent the earliest stages of the most lethal form of ovarian cancer. RECENT FINDINGS: The distal fallopian tube is emerging as an established source of many early serous carcinomas in women with BRCA mutations (BRCA+). Protocols examining the fimbrial (SEE-FIM) end have revealed a noninvasive but potentially lethal form of tubal carcinoma, designated tubal intraepithelial carcinoma. Tubal intraepithelial carcinoma is present in many women with presumed ovarian or peritoneal serous cancer. A candidate precursor to tubal intraepithelial carcinoma, entitled the 'p53 signature', suggests that molecular events associated with serous cancer (p53 mutations) may be detected in benign mucosa. SUMMARY: A fully characterized precursor lesion is a first and necessary step to pelvic serous cancer prevention. The emerging data offer compelling evidence for a model of 'fimbrial-ovarian' serous neoplasia, and call attention to the distal fallopian tube as an important source for this disease, the study of which could clarify pathways to cancer in both organs and generate novel strategies for cancer prevention.

Original languageEnglish
Pages (from-to)3-9
Number of pages7
JournalCurrent Opinion in Obstetrics and Gynecology
Volume19
Issue number1
DOIs
StatePublished - Feb 1 2007
Externally publishedYes

Fingerprint

Fallopian Tubes
Carcinogenesis
Carcinoma in Situ
Pelvic Neoplasms
Neoplasms
Carcinoma
Mutation
Ovarian Neoplasms
Mucous Membrane
Research

Keywords

  • BRCA
  • Fallopian tube
  • Fimbria
  • Intraepithelial carcinoma
  • Ovarian neoplasms
  • p53
  • Primary peritoneal serous carcinoma
  • Serous carcinoma

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

The distal fallopian tube : A new model for pelvic serous carcinogenesis. / Crum, Christopher P.; Drapkin, Ronny; Miron, Alexander; Ince, Tan; Muto, Michael; Kindelberger, David W.; Lee, Yonghee.

In: Current Opinion in Obstetrics and Gynecology, Vol. 19, No. 1, 01.02.2007, p. 3-9.

Research output: Contribution to journalArticle

Crum, Christopher P. ; Drapkin, Ronny ; Miron, Alexander ; Ince, Tan ; Muto, Michael ; Kindelberger, David W. ; Lee, Yonghee. / The distal fallopian tube : A new model for pelvic serous carcinogenesis. In: Current Opinion in Obstetrics and Gynecology. 2007 ; Vol. 19, No. 1. pp. 3-9.
@article{f815b0386afe4712bce953c001edea52,
title = "The distal fallopian tube: A new model for pelvic serous carcinogenesis",
abstract = "PURPOSE OF REVIEW: Research over the past 50 years has yielded little concrete information on the source of pelvic serous cancer in women, creating a knowledge gap that has adversely influenced our ability to identify, remove or prevent the earliest stages of the most lethal form of ovarian cancer. RECENT FINDINGS: The distal fallopian tube is emerging as an established source of many early serous carcinomas in women with BRCA mutations (BRCA+). Protocols examining the fimbrial (SEE-FIM) end have revealed a noninvasive but potentially lethal form of tubal carcinoma, designated tubal intraepithelial carcinoma. Tubal intraepithelial carcinoma is present in many women with presumed ovarian or peritoneal serous cancer. A candidate precursor to tubal intraepithelial carcinoma, entitled the 'p53 signature', suggests that molecular events associated with serous cancer (p53 mutations) may be detected in benign mucosa. SUMMARY: A fully characterized precursor lesion is a first and necessary step to pelvic serous cancer prevention. The emerging data offer compelling evidence for a model of 'fimbrial-ovarian' serous neoplasia, and call attention to the distal fallopian tube as an important source for this disease, the study of which could clarify pathways to cancer in both organs and generate novel strategies for cancer prevention.",
keywords = "BRCA, Fallopian tube, Fimbria, Intraepithelial carcinoma, Ovarian neoplasms, p53, Primary peritoneal serous carcinoma, Serous carcinoma",
author = "Crum, {Christopher P.} and Ronny Drapkin and Alexander Miron and Tan Ince and Michael Muto and Kindelberger, {David W.} and Yonghee Lee",
year = "2007",
month = "2",
day = "1",
doi = "10.1097/GCO.0b013e328011a21f",
language = "English",
volume = "19",
pages = "3--9",
journal = "Current Opinion in Obstetrics and Gynecology",
issn = "1040-872X",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - The distal fallopian tube

T2 - A new model for pelvic serous carcinogenesis

AU - Crum, Christopher P.

AU - Drapkin, Ronny

AU - Miron, Alexander

AU - Ince, Tan

AU - Muto, Michael

AU - Kindelberger, David W.

AU - Lee, Yonghee

PY - 2007/2/1

Y1 - 2007/2/1

N2 - PURPOSE OF REVIEW: Research over the past 50 years has yielded little concrete information on the source of pelvic serous cancer in women, creating a knowledge gap that has adversely influenced our ability to identify, remove or prevent the earliest stages of the most lethal form of ovarian cancer. RECENT FINDINGS: The distal fallopian tube is emerging as an established source of many early serous carcinomas in women with BRCA mutations (BRCA+). Protocols examining the fimbrial (SEE-FIM) end have revealed a noninvasive but potentially lethal form of tubal carcinoma, designated tubal intraepithelial carcinoma. Tubal intraepithelial carcinoma is present in many women with presumed ovarian or peritoneal serous cancer. A candidate precursor to tubal intraepithelial carcinoma, entitled the 'p53 signature', suggests that molecular events associated with serous cancer (p53 mutations) may be detected in benign mucosa. SUMMARY: A fully characterized precursor lesion is a first and necessary step to pelvic serous cancer prevention. The emerging data offer compelling evidence for a model of 'fimbrial-ovarian' serous neoplasia, and call attention to the distal fallopian tube as an important source for this disease, the study of which could clarify pathways to cancer in both organs and generate novel strategies for cancer prevention.

AB - PURPOSE OF REVIEW: Research over the past 50 years has yielded little concrete information on the source of pelvic serous cancer in women, creating a knowledge gap that has adversely influenced our ability to identify, remove or prevent the earliest stages of the most lethal form of ovarian cancer. RECENT FINDINGS: The distal fallopian tube is emerging as an established source of many early serous carcinomas in women with BRCA mutations (BRCA+). Protocols examining the fimbrial (SEE-FIM) end have revealed a noninvasive but potentially lethal form of tubal carcinoma, designated tubal intraepithelial carcinoma. Tubal intraepithelial carcinoma is present in many women with presumed ovarian or peritoneal serous cancer. A candidate precursor to tubal intraepithelial carcinoma, entitled the 'p53 signature', suggests that molecular events associated with serous cancer (p53 mutations) may be detected in benign mucosa. SUMMARY: A fully characterized precursor lesion is a first and necessary step to pelvic serous cancer prevention. The emerging data offer compelling evidence for a model of 'fimbrial-ovarian' serous neoplasia, and call attention to the distal fallopian tube as an important source for this disease, the study of which could clarify pathways to cancer in both organs and generate novel strategies for cancer prevention.

KW - BRCA

KW - Fallopian tube

KW - Fimbria

KW - Intraepithelial carcinoma

KW - Ovarian neoplasms

KW - p53

KW - Primary peritoneal serous carcinoma

KW - Serous carcinoma

UR - http://www.scopus.com/inward/record.url?scp=33846185401&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846185401&partnerID=8YFLogxK

U2 - 10.1097/GCO.0b013e328011a21f

DO - 10.1097/GCO.0b013e328011a21f

M3 - Article

C2 - 17218844

AN - SCOPUS:33846185401

VL - 19

SP - 3

EP - 9

JO - Current Opinion in Obstetrics and Gynecology

JF - Current Opinion in Obstetrics and Gynecology

SN - 1040-872X

IS - 1

ER -